For the year ending 2025-12-31, OLPX had -$267,236K decrease in cash & cash equivalents over the period. $58,329K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net sales | 422,960 |
| Cost of product (excluding amortization) | 119,329 |
| Marketing expenses | 97,051 |
| Adjusted selling, general, and administrative | 109,579 |
| Depreciation and amortization | 53,912 |
| Interest expense | 41,342 |
| Interest income | 14,828 |
| Tax receivable agreement liability adjustment | 12,118 |
| Income tax provision | 3,075 |
| Share-based compensation expense | 13,285 |
| Other segment expenses | 21,585 |
| Net (loss) income | -9,252 |
| Amortization of patent formulations | 9,985 |
| Amortization of other intangibles | 43,582 |
| Inventory write-off and disposal | 5,568 |
| Depreciation of property and equipment | 345 |
| Amortization of debt issuance costs | 3,889 |
| Deferred taxes | 1,277 |
| Tax receivable agreement liability adjustment | 12,118 |
| Share-based compensation expense | 13,285 |
| Acquisition-related costs in investing activities | 9,305 |
| Other | -1,743 |
| Accounts receivable, net | 14,498 |
| Inventory | -8,497 |
| Prepaid expenses and other current assets | 48,784 |
| Accounts payable | -2,116 |
| Accrued expenses and other current liabilities | 50,346 |
| Other assets and liabilities | 2,394 |
| Net cash provided by operating activities | 58,660 |
| Purchase of property and equipment | 331 |
| Acquisition-related costs | 10,633 |
| Purchase of intangible assets | 0 |
| Purchase and development of software | 1,642 |
| Net cash used in investing activities | -12,606 |
| Proceeds from exercise of stock options | 527 |
| Principal payments of 2022 term loan facility | 301,688 |
| Payment related to shares withheld to cover tax withholding obligations for options and for sars-Employee Stock Option | 0 |
| Payment related to shares withheld to cover tax withholding obligations for options and for sars-Stock Appreciation Rights SARS | 0 |
| Payments made pursuant to tax receivable agreement | 12,129 |
| Net cash used in financing activities | -313,290 |
| Net (decrease) increase in cash and cash equivalents | -267,236 |
| Cash and cash equivalents - beginning of year | 585,967 |
| Cash and cash equivalents - end of year | 318,731 |
OLAPLEX HOLDINGS, INC. (OLPX)
OLAPLEX HOLDINGS, INC. (OLPX)